Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,937 | 303 | 99.8% |
| Education | $5.40 | 1 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $537.19 | 50 | $0 (2020) |
| PFIZER INC. | $505.93 | 99 | $0 (2020) |
| Amgen Inc. | $296.81 | 31 | $0 (2019) |
| AstraZeneca Pharmaceuticals LP | $289.44 | 10 | $0 (2022) |
| GlaxoSmithKline, LLC. | $278.98 | 36 | $0 (2018) |
| Novo Nordisk Inc | $142.87 | 11 | $0 (2019) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $142.16 | 12 | $0 (2019) |
| SANOFI-AVENTIS U.S. LLC | $127.26 | 14 | $0 (2019) |
| Amarin Pharma Inc. | $105.00 | 6 | $0 (2019) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $87.05 | 6 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $15.48 | 1 | AstraZeneca Pharmaceuticals LP ($15.48) |
| 2021 | $12.98 | 1 | AbbVie Inc. ($12.98) |
| 2020 | $52.55 | 4 | Allergan, Inc. ($16.02) |
| 2019 | $791.05 | 74 | Janssen Pharmaceuticals, Inc ($162.62) |
| 2018 | $1,067 | 126 | Janssen Pharmaceuticals, Inc ($223.67) |
| 2017 | $1,004 | 98 | PFIZER INC. ($160.20) |
All Payment Transactions
304 individual payment records from CMS Open Payments — Page 1 of 13
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 03/03/2022 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $15.48 | General |
| Category: Respiratory | ||||||
| 11/18/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $12.98 | General |
| Category: NEUROSCIENCE | ||||||
| 03/09/2020 | Allergan, Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $16.02 | General |
| Category: NEUROSCIENCE | ||||||
| 02/04/2020 | Janssen Pharmaceuticals, Inc | INVOKANA (Drug), XARELTO | Food and Beverage | In-kind items and services | $14.04 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 01/14/2020 | Lilly USA, LLC | TRULICITY (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $11.48 | General |
| Category: Diabetes | ||||||
| 01/09/2020 | PFIZER INC. | CHANTIX (Drug), EUCRISA, COLOGUARD | Food and Beverage | In-kind items and services | $11.01 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 12/30/2019 | PFIZER INC. | CHANTIX (Drug), ELIQUIS | Food and Beverage | In-kind items and services | $11.15 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 12/16/2019 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $18.79 | General |
| Category: Hypertriglyceridemia | ||||||
| 12/11/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug), INVOKANA | Food and Beverage | In-kind items and services | $11.60 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 12/10/2019 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $20.19 | General |
| Category: Anemia | ||||||
| 12/03/2019 | Merck Sharp & Dohme Corporation | ROTATEQ (Biological), PNEUMOVAX 23, VAQTA | Food and Beverage | In-kind items and services | $10.82 | General |
| Category: VACCINE | ||||||
| 12/02/2019 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $15.78 | General |
| Category: Hypertriglyceridemia | ||||||
| 11/27/2019 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $11.23 | General |
| Category: PSYCHIATRY | ||||||
| 11/14/2019 | PFIZER INC. | CHANTIX (Drug), EUCRISA, COLOGUARD | Food and Beverage | In-kind items and services | $11.34 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 11/13/2019 | Amgen Inc. | Aimovig (Biological), Repatha | Food and Beverage | In-kind items and services | $16.47 | General |
| Category: Neuroscience | ||||||
| 11/06/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug), INVOKANA | Food and Beverage | In-kind items and services | $8.99 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 10/31/2019 | Janssen Pharmaceuticals, Inc | INVOKANA (Drug) | Food and Beverage | In-kind items and services | $11.84 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 10/31/2019 | PFIZER INC. | CHANTIX (Drug), EUCRISA, COLOGUARD | Food and Beverage | In-kind items and services | $1.13 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 10/16/2019 | Novo Nordisk Inc | Xultophy 100/3.6 (Drug) | Food and Beverage | In-kind items and services | $14.13 | General |
| Category: Diabetes | ||||||
| 10/10/2019 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | TRULANCE (Drug), XIFAXAN | Food and Beverage | In-kind items and services | $18.43 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/03/2019 | PFIZER INC. | CHANTIX (Drug) | Food and Beverage | In-kind items and services | $6.10 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 08/19/2019 | Amgen Inc. | Aimovig (Biological), Repatha | Food and Beverage | In-kind items and services | $7.16 | General |
| Category: Neuroscience | ||||||
| 08/14/2019 | SANOFI-AVENTIS U.S. LLC | PRALUENT (Drug) | Food and Beverage | In-kind items and services | $12.12 | General |
| Category: CARDIOVASCULAR | ||||||
| 08/07/2019 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $19.43 | General |
| Category: Hypertriglyceridemia | ||||||
| 08/02/2019 | Janssen Pharmaceuticals, Inc | INVOKANA (Drug) | Food and Beverage | In-kind items and services | $11.09 | General |
| Category: Cardiovascular & Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2022 | 10 | 782 | 963 | $129,182 | $31,578 |
| 2021 | 17 | 1,889 | 2,964 | $290,261 | $83,964 |
| 2020 | 21 | 2,222 | 3,433 | $333,717 | $87,046 |
All Medicare Procedures & Services
48 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 174 | 234 | $71,370 | $14,233 | 19.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 64 | 64 | $21,056 | $8,020 | 38.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 72 | 87 | $18,009 | $3,938 | 21.9% |
| 87636 | Detection test by multiplex amplified probe technique for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (covid-19) and influenza virus types a and b | Office | 2022 | 15 | 15 | $6,420 | $2,129 | 33.2% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 247 | 338 | $3,042 | $1,003 | 33.0% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 15 | 15 | $3,225 | $978.90 | 30.4% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 15 | 15 | $750.00 | $417.45 | 55.7% |
| 81003 | Automated urinalysis test | Office | 2022 | 148 | 162 | $3,240 | $359.43 | 11.1% |
| 71046 | X-ray of chest, 2 views | Office | 2022 | 14 | 15 | $1,260 | $285.67 | 22.7% |
| 80305 | Testing for presence of drug, read by direct observation | Office | 2022 | 18 | 18 | $810.00 | $213.03 | 26.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 223 | 419 | $127,795 | $33,645 | 26.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 129 | 129 | $42,441 | $16,299 | 38.4% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 129 | 212 | $43,884 | $12,405 | 28.3% |
| 90662 | Vaccine for influenza for injection into muscle, split virus, preservation free | Office | 2021 | 108 | 108 | $23,150 | $7,027 | 30.4% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2021 | 693 | 1,149 | $10,341 | $3,430 | 33.2% |
| 87636 | Sarscov2 & inf a&b amp prb | Office | 2021 | 19 | 19 | $8,132 | $2,567 | 31.6% |
| 90732 | Vaccine for pneumococcal polysaccharide for injection beneath the skin or into muscle, patient 2 years or older | Office | 2021 | 17 | 17 | $6,290 | $2,117 | 33.7% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 112 | 112 | $5,600 | $1,773 | 31.7% |
| 85610 | Blood test, clotting time | Office | 2021 | 38 | 248 | $3,968 | $1,060 | 26.7% |
| 81003 | Automated urinalysis test | Office | 2021 | 282 | 388 | $7,760 | $873.00 | 11.3% |
| 0003A | Fee covid-19 vac 1 booster | Office | 2021 | 21 | 21 | $1,785 | $781.41 | 43.8% |
| 71046 | X-ray of chest, 2 views | Office | 2021 | 32 | 34 | $2,856 | $737.41 | 25.8% |
| 80305 | Testing for presence of drug, read by direct observation | Office | 2021 | 29 | 30 | $1,350 | $378.00 | 28.0% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2021 | 12 | 32 | $2,240 | $269.50 | 12.0% |
| 82274 | Stool analysis for blood, by fecal hemoglobin determination by immunoassay | Office | 2021 | 14 | 15 | $975.00 | $238.80 | 24.5% |
About Dr. Pete Mayfield, M.D
Dr. Pete Mayfield, M.D is a Internal Medicine healthcare provider based in Clarksville, Indiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/19/2006. The National Provider Identifier (NPI) number assigned to this provider is 1396700647.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Pete Mayfield, M.D has received a total of $2,942 in payments from pharmaceutical and medical device companies, with $15.48 received in 2022. These payments were reported across 304 transactions from 26 companies. The most common payment nature is "Food and Beverage" ($2,937).
As a Medicare-enrolled provider, Mayfield has provided services to 4,893 Medicare beneficiaries, totaling 7,360 services with total Medicare billing of $202,588. Data is available for 3 years (2020–2022), covering 48 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Other Specialties Internal Medicine
- Location Clarksville, IN
- Active Since 04/19/2006
- Last Updated 01/20/2021
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1396700647
Products in Payments
- CHANTIX (Drug) $338.30
- XARELTO (Drug) $314.78
- INVOKANA (Drug) $222.41
- SYMBICORT (Drug) $137.01
- Aimovig (Biological) $122.01
- FARXIGA (Drug) $115.84
- Vascepa (Drug) $105.00
- VIAGRA (Drug) $78.44
- TRIUMEQ (Drug) $72.26
- BREO (Drug) $69.55
- SHINGRIX (Biological) $65.52
- PRALUENT (Drug) $65.43
- RELISTOR (Drug) $54.59
- Enbrel (Biological) $51.41
- SOLIQUA (Drug) $50.19
- Repatha (Biological) $47.58
- REXULTI (Drug) $46.82
- LYRICA (Drug) $45.71
- FreeStyle Libre Pro (Device) $45.36
- ANORO (Drug) $45.18
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Clarksville
Stephen White, Md, MD
Internal Medicine — Payments: $15,089
Olaide Ajayi, M.d, M.D
Internal Medicine — Payments: $10,834
Dr. Devabrata Ganguly, M.d, M.D
Internal Medicine — Payments: $7,224
Dr. Marty Odom, Md, MD
Internal Medicine — Payments: $6,476
Steven Goldstein, Md, MD
Internal Medicine — Payments: $4,313
Giavonne Rondo-Hillman, Md, MD
Internal Medicine — Payments: $3,904